HALO
NASDAQ · Biotechnology
Halozyme Therapeutics Inc
$111.45
-1.00 (-0.89%)
Analyst Consensus
Strong Buy
16
Analysts
High
Coverage
Price Target
Analyst Price Target
-81.1% upside
Low Target
$15.29
Average Target
$21.02
High Target
$24.22
Current Price
$111.45
Current
$111.45
$111.45
Target
$21.02
$21.02
$15.29
$21.02 avg
$24.22
Scenario Analysis
Bear Case
$15.29
-86.3%
Low target
Base Case
$21.02
-81.1%
Avg target
Bull Case
$24.22
+-78.3%
High target
Risk/Reward
0.9x
Unfavorable
Price in Context
52-Week High
$111.15
0.3% from high
52-Week Low
$61.23
+82.0% from low
50-Day SMA
$71.23
+56.5% vs SMA
200-Day SMA
$65.75
+69.5% vs SMA
RSI (14)
47.6
Neutral
Target vs 52W High
$21.02
-81.1% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -2.6% |
| AMGN | Hold | 43 | 47% | $190.87 | -51.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +140.9% |
| VRTX | Strong Buy | 36 | 81% | $438.34 | -14.2% |
| REGN | Buy | 38 | 68% | $76.80 | -90.4% |
| MRNA | Hold | 30 | 37% | $149.45 | -13.6% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -61.4% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -40.8% |